贫血是慢性肾功能不全的常见合并症,其中促红细胞生成素(EPO)缺乏是贫血的最主要原因,而左卡尼汀缺乏致红细胞脆性增加,红细胞寿命缩短,是导致肾性贫血另一重要因素,为此我们联合应用左卡尼汀及EPO治疗肾性贫血观察左卡尼汀对EPO疗效的影响。1资料与方法1·1一般资料2003年1月 Anemia is a common complication of chronic renal insufficiency. Erythropoietin (EPO) deficiency is the leading cause of anemia. Lack of erythrochlonitine causes an increase in the fragility of erythrocytes and a shortened life span of red blood cells. This is another important cause of renal anemia Factors, for which we combined the application of levocarnitine and EPO treatment of renal anemia observed levocarnitine EPO curative effect. 1 Materials and Methods 1.1 General Information January 2003